Proteomics

Dataset Information

0

Spatiotemporal proteomic profiling of Huntington's disease mice reveals widespread loss of protein function


ABSTRACT: Huntington's disease (HD) is characterized by the aggregation of polyglutamine-expanded huntingtin (HTT), proceeding from soluble oligomers to end-stage inclusions. The molecular mechanisms of how protein aggregation leads to neuronal dysfunction are not well understood. We employed mass spectrometry-based quantitative proteomics to dissect spatiotemporal mechanisms of neurodegeneration using the R6/2 mouse model of HD. We show that extensive remodeling of the soluble brain proteome correlates with changes in insoluble aggregate formation during disease progression. In-depth characterization of HTT inclusion bodies uncovered an unprecedented complexity of several hundred proteins. Sequestration to inclusions was dependent on protein expression levels and the presence of aggregation-prone amino acid sequence features, such as low-complexity regions or coiled-coil domains. Overexpression of several sequestered proteins ameliorated HTT toxicity and modified the aggregation behavior in an in vitro model of HD. Our study provides a comprehensive and spatiotemporally-resolved proteome resource of HD progression, indicating that widespread loss of protein function contributes to aggregate-mediated toxicity.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

DISEASE(S): Huntington Disease

SUBMITTER: Mario Oroshi  

LAB HEAD: Matthias Mann

PROVIDER: PXD004973 | Pride | 2017-11-24

REPOSITORIES: Pride

altmetric image

Publications

Spatiotemporal Proteomic Profiling of Huntington's Disease Inclusions Reveals Widespread Loss of Protein Function.

Hosp Fabian F   Gutiérrez-Ángel Sara S   Schaefer Martin H MH   Cox Jürgen J   Meissner Felix F   Hipp Mark S MS   Hartl F-Ulrich FU   Klein Rüdiger R   Dudanova Irina I   Mann Matthias M  

Cell reports 20171101 8


Aggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington's disease (HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates and how they lead to neuronal dysfunction is not well understood. We employed mass spectrometry (MS)-based quantitative proteomics to dissect spatiotemporal mechanisms of neurodegeneration using the R6/2 mouse model of HD. Extensive remodeling of the soluble brain proteome correlated with insoluble aggregate formation  ...[more]

Similar Datasets

2014-10-10 | E-GEOD-62210 | biostudies-arrayexpress
2014-10-10 | GSE62210 | GEO
2024-03-13 | PXD026012 | Pride
2014-10-10 | E-GEOD-38218 | biostudies-arrayexpress
2014-10-10 | E-GEOD-38219 | biostudies-arrayexpress
2018-06-20 | GSE115990 | GEO
2014-10-10 | GSE38219 | GEO
2014-10-10 | GSE38218 | GEO
2024-07-12 | GSE272134 | GEO
2018-06-14 | PXD009803 | Pride